Refractive Surgery News

In this video perspective from the virtual American Society of Cataract and Refractive Surgery meeting, H. John Shammas, MD, director of the Shammas Eye Center in Southern California, discusses the advantages he sees in using the Argos swept-source OCT biometer (Movu). Through a strategic alliance, the Argos has been incorporated into Alcon’s cataract and refractive surgical suite of products.

Patients with presbyopia who underwent laser scleral microporation experienced visual acuity improvements at 3 months when compared with baseline, according to a speaker at the virtual American Society of Cataract and Refractive Surgery meeting

Patients who received one preoperative drop of Alphagan P experienced significantly less bulbar redness after femtosecond laser-assisted cataract surgery compared with patients who received only traditional preoperative eye drops, according to a speaker at the virtual American Society of Cataract and Refractive Surgery meeting.

Although we use all of the modern presbyopic IOLs In our practice, two lens types now dominate our presbyopic approach. The first is the Alcon PanOptix, and the second is the RxSight Light Adjustable Lens with monovision. Although both lenses do a fantastic job, there are differences.

A novel technique of intrastromal lenticule rotation effectively treats high astigmatism up to 10 D in a minimally invasive manner, according to two specialists.

Currently available IOLs offer a wide range of options and increasing opportunities for personalized selection. The FDA approval in August 2019 of Alcon’s AcrySof IQ PanOptix trifocal IOL, the first of its kind in the U.S., further enriched the market. Although the perfect lens that satisfies all needs without compromise is not yet there, and careful case-by-case evaluation is still required, the chances of satisfying patients are much greater than in the past.

The first IOL was implanted by Sir Harold Ridley on Nov. 29, 1949, at St. Thomas’ Hospital in London. Amazing to me, it was a monofocal posterior chamber lens, or PCL, manufactured by Rayner and implanted after large-incision extracapsular cataract extraction. Sixty years later, the procedure of PCLs implanted after small-incision ECCE with the nucleus removed by phacoemulsification in more affluent countries and manually in less affluent countries remains dominant.

Patients who received the first FDA-approved trifocal IOL reported high satisfaction with the lens, but some can experience some contrast or quality diminution even with final 20/20 vision, according to a speaker at the virtual American Society of Cataract and Refractive Surgery meeting.

In this video perspective from the virtual American Society of Cataract and Refractive Surgery meeting, Jason Jones, MD, discusses his study comparing defocus curves and visual results of the Tecnis Symfony Plus extended depth of focus IOL (Johnson & Johnson Vision) with a monofocal IOL.

In this video perspective from the virtual American Society of Cataract and Refractive Surgery meeting, John A. Hovanesian, MD, FACS, discusses a study showing high patient satisfaction in those implanted bilaterally with the Alcon PanOptix trifocal IOL.